Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies Establishes $750M Credit Facility

NEW YORK (GenomeWeb News) – Life Technologies has entered into an agreement to establish a $750 million revolving credit facility, it disclosed in a document filed with the US Securities and Exchange Commission after the close of the market on Tuesday.

Bank of America is the administrative agent, swing line lender, and L/C issuer under the arrangement. Life Tech along with Applied Biosystems BV, Life Technologies Europe BV, and Life Technologies Finance Limited have the right to borrow under the facility.

The facility replaces an earlier $500 million amended and restated credit agreement entered into on May 28, 2010.

Proceeds will go toward ongoing working capital and general corporate purposes of Life Tech and its subsidiaries, it said. The facility terminates on Feb. 14, 2017, at which time all amounts outstanding, plus accrued interest, will be due.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.